Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in Resistant Seronegative Oligoarthritis of the Knee
NCT01216631Phase 2Terminated
- Sponsor
- University of Leeds
- Start
- Sep 2010
- Primary completion
- Aug 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of infliximab in oligoarthritis (3 arms), sponsored by University of Leeds. Primary endpoint: Ultrasound Synovitis Score at 8 weeks. Started Sep 2010; status: terminated.
02
Drugs
infliximab
03
Conditions
oligoarthritis
Beyond the preview
Go deeper on NCT01216631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216631.